86 research outputs found
Aplicaciones web para prácticas de esquemas algorítmicos
Debido a las dificuldades del aprendizaje inicial
de las asignaturas de algoritmos en las
carreras de Informática, se trabaja en el desarrollo
de una aplicación Web que guíe y mejore
el aprendizaje y la resolución de problemas
mediante esquemas algorítmicos. La idea
es dar soporte a un ambiente de desarrollo común para alumnos y profesores, en el que se seguirá una estructura definida previamente en la utilización de los esquemas algorítmicos. El
alumno deberá utilizar en el desarrollo de las
prácticas los esquemas proporcionados, completando
los huecos correspondientes a las funciones
que aparecen en ellos, con lo que se pretende
corregir la tendencia en una aproximación
inicial a los algoritmos de alejarse de los
esquemas, lo que produce un gasto de tiempo
importante hasta que se comprende la importancia de los esquemas algorítmicos básicos.Peer Reviewe
Influence of temperature on PA 6−steel contacts in the presence of an ionic liquid lubricant. Poster
Room−temperature ionic liquids (ILs) are salts with a melting point lower than room temperature
and are called green solvents because they have properties such as:
♦ Non−flammability,
♦ Negligible volatility, and
♦ High thermal stability.
The high thermal stability range (from −74 ºC to 370 ºC in our case) of ILs makes them suitable
candidates as high temperature and extreme temperature lubricants. In this work we present the
mechanical and tribological properties of polyamide 6−IL dispersion (PA 6+3wt.% IL) under variable
load and temperature conditions, against AISI 52100 steel or AISI 316L stainless steel.We wish to thank MEC (Spain) and the EU FEDER program (MAT2002−03947 and MAT2005−00067) and the
Fundación Séneca (Región de Murcia, Spain) (PI/00447/FS/04) for financial support. A.E. Jiménez is grateful for a
research grant
Prevalence of bleeding secondary to anticoagulation and mortality in patients with atrial fibrillation admitted with SARS-CoV-2 infection
Supplementary data associated with this article can befound, in the online version, at
https://doi.org/10.1016/j.medcli.2021.06.015Introduction and purpose: Atrial fibrillation (AF) is common in patients admitted with severe COVID-
19. However, there is limited data about the management of chronic anticoagulation therapy in these
patients. We assessed the anticoagulation and incidence of major cardiovascular events in hospitalized
patients with AF and COVID-19.
Methods: We retrospectively investigated all consecutive patients with AF admitted with COVID-19
between March and May 2020 in 9 Spanish hospitals. We selected a control group of non-AF patients
consecutively admitted with COVID-19. We compared baseline characteristics, incidence of major bleed-
ing, thrombotic events and mortality. We used propensity score matching (PSM) to minimize potential
confounding variables, as well as a multivariate analysis to predict major bleeding and death.
Results: 305 patients admitted with AF and COVID-19 were included. After PSM, 151 AF patients were
matched with 151 control group patients. During admission, low-molecular-weight heparin was the
principal anticoagulant and the incidence of major bleeding and mortality were higher in the AF group
[16 (10.6%) vs 3 (2%), p = 0.003; 52 (34.4%) vs 35 (23.2%), p = 0.03, respectively]. The multivariate analysis
showed the presence of AF as independent predictor of in-hospital major bleeding and mortality in
COVID-19 patients. In AF group, a secondary multivariate analysis identified high levels of D-dimer as
independent predictor of in-hospital major bleeding.
Conclusions: AF patients admitted with COVID-19 represent a population at high risk for bleeding and
mortality during admission. It seems advisable to individualize anticoagulation therapy during admission,
considering patient specific bleeding and thrombotic risk.Antecedentes y objetivos: La fibrilación auricular (FA) es frecuente en pacientes ingresados por COVID-19
grave. Sin embargo, los datos sobre el manejo de la anticoagulación crónica en estos pacientes son escasos.
Analizamos la anticoagulación y la incidencia de episodios cardiovasculares mayores en pacientes con FA
ingresados por la COVID-19.
Métodos: Retrospectivamente, se identificaron todos los pacientes con FA ingresados por la COVID-19
entre marzo y mayo de 2020, en 9 hospitales espa ̃noles. Se seleccionó un grupo control de pacientes
ingresados consecutivamente por la COVID-19 sin FA. Se compararon las características basales, inci-
dencia de hemorragias mayores, episodios trombóticos y mortalidad. Para reducir potenciales factores de
confusión se realizó un emparejamiento por puntuación de propensión, así como un análisis multivariante
para predecir hemorragia mayor y mortalidad.
Resultados: Se incluyeron 305 pacientes con FA ingresados por la COVID-19. Tras el emparejamiento
por puntuación de propensión, 151 pacientes con FA fueron emparejados con 151 controles. Durante el
ingreso, la heparina de bajo peso molecular fue el principal anticoagulante y la incidencia de hemorragia
mayor y mortalidad fue mayor en el grupo de FA (16[10,6%] vs. 3[2%], p = 0,003; 52[34,4%] vs. 35[23,2%],
p = 0,03, respectivamente). El análisis multivariante demostró la presencia de FA como predictor indepen-
diente de sangrados y mortalidad intrahospitalaria en los pacientes con la COVID-19. En el grupo de FA,
un segundo análisis multivariante identificó valores elevados de dímero-D como predictor independiente
de hemorragia mayor intrahospitalaria.
Conclusiones: Los pacientes con FA ingresados por la COVID-19 representan una población de alto riesgo
de sangrado y mortalidad durante el ingreso. Parece recomendable individualizar la anticoagulación
durante el ingreso, considerando el riesgo específico de sangrado y trombosis
Seed Viability, Spikelet Dispersal, Seed Banks and Seed Storage Requirements for Native and Invasive Cordgrasses (Genus Spartina) in Southwest Iberian Peninsula
Seed banks play an important role in determining the spatial and temporal distribution of halophytes in salt marshes. We
tested the ability of native Spartina maritima and invasive S. densiflora spikelets to disperse by flotation on water with different
salinity concentrations, and the longevity of spikelet viability relative to environmental conditions including dry or
wet storage at low or moderate temperatures, and aqueous salinity concentrations from fresh to sea water. We quantified
pre-dispersal seed production and pre- and post-dispersal focal Spartina spp. presence in seed banks along intertidal gradients
within salt marshes at the Gulf of Cádiz (Southwest Iberian Peninsula). Spartina densiflora spikelets, especially from
middle and high elevation marshes, showed greater ability than S. maritima to remain afloat, which suggests this species
could be dispersed over longer distances. Wet-stored Spartina seeds were able to maintain viability for months, while seeds
under dry storage rapidly lost viability. This decline was most significant for S. maritima, and for seeds stored at moderate
temperatures. Storage of spikelets under wet and cold conditions optimized spikelet viability. Native S. maritima did not
establish transient or persistent seed banks, while invasive S. densiflora established transient seed banks mainly at higher
marsh elevations. Our results on the dynamics of seed dispersal and seed banks and seedling recruitment provide fundamental
knowledge that can be applied for conservation of native S. maritima, management of invasive S. densiflora, and ecological
restoration of tidal salt marshes.Funding for open access publishing: Universidad de Sevilla / CBUA Open Access funding enabled and organized by Universidad de Sevilla. M.D. Infante-Izquierdo acknowledges to Ministerio de Educación, Cultura y Deporte of Spanish Government for the FPU Grant (FPU14/06556)
The mRNA degradation factor Xrn1 regulates transcription elongation in parallel to Ccr4
Co-transcriptional imprinting of mRNA by Rpb4 and Rpb7 subunits of RNA polymerase II (RNAPII) and by the Ccr4–Not complex conditions its posttranscriptional fate. In turn, mRNA degradation factors like Xrn1 are able to influence RNAPII-dependent transcription, making a feedback loop that contributes to mRNA homeostasis. In this work, we have used repressible yeast GAL genes to perform accurate measurements of transcription and mRNA degradation in a set of mutants. This genetic analysis uncovered a link from mRNA decay to transcription elongation. We combined this experimental approach with computational multi-agent modelling and tested different possibilities of Xrn1 and Ccr4 action in gene transcription. This double strategy brought us to conclude that both Xrn1-decaysome and Ccr4–Not regulate RNAPII elongation, and that they do it in parallel. We validated this conclusion measuring TFIIS genome-wide recruitment to elongating RNAPII. We found that xrn1Δ and ccr4Δ exhibited very different patterns of TFIIS versus RNAPII occupancy, which confirmed their distinct role in controlling transcription elongation. We also found that the relative influence of Xrn1 and Ccr4 is different in the genes encoding ribosomal proteins as compared to the rest of the genome
Heterozygous Arrhythmogenic Cardiomyopathy-desmoplakin Mutation Carriers Exhibit a Subclinical Cutaneous Phenotype with Cell Membrane Disruption and Lack of Intercellular Adhesion
Genetic variants that result in truncation in desmoplakin (DSP) are a known cause of
arrhythmogenic cardiomyopathy (AC). In homozygous carriers, the combined involvement of skin
and heart muscle is well defined, however, this is not the case in heterozygous carriers. The aim of
this work is to describe cutaneous findings and analyze the molecular and ultrastructural cutaneous
changes in this group of patients. Four women and eight men with a mean age of 48 ± 14 years
were included. Eight met definitive criteria for AC, one was borderline and three were silent carriers.
No relevant macroscopic changes in skin and hair were detected. However, significantly lower skin
temperature (29.56 vs. 30.97 ◦C, p = 0.036) and higher transepidermal water loss (TEWL) (37.62 vs.
23.95 g m 2 h 1, p = 0.028) were observed compared to sex- and age-matched controls. Histopathology
of the skin biopsy showed widening of intercellular spaces and acantholysis of keratinocytes in the
spinous layer. Immunohistochemistry showed a strongly reduced expression of DSP in all samples.
Trichogram showed regular nodules (thickening) compatible with pseudomonilethrix. Therefore,
regardless of cardiac involvement, heterozygous patients with truncation-type variants in DSP have
lower skin temperature and higher TEWL, constant microscopic skin involvement with specific
patterns and pseudomonilethrix in the trichogram.Andalusian Society of Cardiology with a “beca de
Investigación general
Emery-Dreifuss Muscular Dystrophy 1 is associated with high risk of malignant ventricular arrhythmias and end-stage heart failure.
BACKGROUND AND AIMS
Emery-Dreifuss muscular dystrophy (EDMD) is caused by variants in EMD (EDMD1) and LMNA (EDMD2). Cardiac conduction defects and atrial arrhythmia are common to both, but LMNA variants also cause end-stage heart failure (ESHF) and malignant ventricular arrhythmia (MVA). This study aimed to better characterise the cardiac complications of EMD variants.
METHODS
Consecutively referred EMD variant-carriers were retrospectively recruited from 12 international cardiomyopathy units. MVA and ESHF incidence in male and female variant-carriers was determined. Male EMD variant-carriers with a cardiac phenotype at baseline (EMDCARDIAC) were compared to consecutively recruited male LMNA variant-carriers with a cardiac phenotype at baseline (LMNACARDIAC).
RESULTS
Longitudinal follow-up data were available for 38 male and 21 female EMD variant-carriers (mean [SD] ages 33.4 [13.3] and 43.3 [16.8] years, respectively). Nine (23.6%) males developed MVA and five (13.2%) developed ESHF during a median [IQR] follow-up of 65.0 [24.3, 109.5] months. No female EMD variant-carrier had MVA or ESHF, but nine (42.8%) developed a cardiac phenotype at a median [IQR] age of 58.6 [53.2, 60.4] years. Incidence rates for MVA were similar for EMDCARDIAC and LMNACARDIAC (4.8 and 6.6 per 100 person-years, respectively; log-rank p = 0.49). Incidence rates for ESHF were 2.4 and 5.9 per 100 person-years for EMDCARDIAC and LMNACARDIAC, respectively (log-rank p = 0.09).
CONCLUSIONS
Male EMD variant-carriers have a risk of progressive heart failure and ventricular arrhythmias similar to that of male LMNA variant-carriers. Early implantable cardioverter defibrillator implantation and heart failure drug therapy should be considered in male EMD variant-carriers with cardiac disease.The work reported in this publication was funded by: a British Heart
Foundation Clinical Research Training Fellowship to D.E.C. (FS/CRTF/
20/24022); a British Heart Foundation Clinical Research Training fellowship to A.P. (FS/18/82/34024); The Ministry of Health, Italy, project
RC-2022-2773270 to E.B.; the National Institutes of Health (NIH)
(R01HL69071, R01HL116906, R01HL147064, NIH/NCATS UL1
TR002535, and UL1 TR001082) to L.M.; and support from the Rose
Foundation for K.M.S
What can we learn from the innovative school for initial and ongoing teacher training? Research proposal
La formación inicial y permanente del profesorado es señalada como una de las claves fundamentales para la mejora del sistema. Sin embargo, para que esto ocurra, la formación del profesorado debe estar vinculada con prácticas educativas de calidad. En este artículo se defiende la investigación cualitativa en innovación educativa a través de los principios de la Teoría Fundamentada como una manera eficaz de construir una teoría sobre la innovación educativa que sea válida y útil para la transformación positiva del sistema educativo
Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis
Objectives: Opioid-induced constipation (OIC) can affect up to 63% of all patients with cancer. The objectives of this study were to assess quality of life as well as efficacy and safety of naloxegol, in patients with cancer with OIC. Methods: An observational study was made of a cohort of patients with cancer and with OIC exhibiting an inadequate response to laxatives and treated with naloxegol. The sample consisted of adult outpatients with a Karnofsky performance status score ≥50. The Patient Assessment of Constipation Quality of Life Questionnaire (PAC-QOL) and the Patient Assessment of Constipation Symptoms (PAC-SYM) were applied for 3 months. Results: A total of 126 patients (58.2% males) with a mean age of 61.3 years (range 34-89) were included. Clinically relevant improvements (>0.5 points) were recorded in the PAC-QOL and PAC-SYM questionnaires (p<0.0001) from 15 days of treatment. The number of days a week with complete spontaneous bowel movements increased significantly (p<0.0001) from 2.4 to 4.6 on day 15, 4.7 after 1 month and 5 after 3 months. Pain control significantly improved (p<0.0001) during follow-up. A total of 13.5% of the patients (17/126) presented some gastrointestinal adverse reaction, mostly of mild (62.5%) or moderate intensity (25%). Conclusions: Clinically relevant improvements in OIC-related quality of life, number of bowel movements and constipation-related symptoms were recorded as early as after 15 days of treatment with naloxegol in patients with cancer and OIC, with a good safety profile
Predictores de riesgo en una cohorte española con cardiolaminopatías. Registro REDLAMINA
[Abstract]
Introduction and objectives.
According to sudden cardiac death guidelines, an implantable cardioverter-defibrillator (ICD) should be considered in patients with LMNA-related dilated cardiomyopathy (DCM) and ≥ 2 risk factors: male sex, left ventricular ejection fraction (LVEF) < 45%, nonsustained ventricular tachycardia (NSVT), and nonmissense genetic variants. In this study we aimed to describe the clinical characteristics of carriers of LMNA genetic variants among individuals from a Spanish cardiac-laminopathies cohort (REDLAMINA registry) and to assess previously reported risk criteria.
Methods.
The relationship between risk factors and cardiovascular events was evaluated in a cohort of 140 carriers (age ≥ 16 years) of pathogenic LMNA variants (54 probands, 86 relatives). We considered: a) major arrhythmic events (MAE) if there was appropriate ICD discharge or sudden cardiac death; b) heart failure death if there was heart transplant or death due to heart failure.
Results.
We identified 11 novel and 21 previously reported LMNA-related DCM variants. LVEF < 45% (P = .001) and NSVT (P < .001) were related to MAE, but not sex or type of genetic variant. The only factor independently related to heart failure death was LVEF < 45% (P < .001).
Conclusions.
In the REDLAMINA registry cohort, the only predictors independently associated with MAE were NSVT and LVEF < 45%. Therefore, female carriers of missense variants with either NSVT or LVEF < 45% should not be considered a low-risk group. It is important to individualize risk stratification in carriers of LMNA missense variants, because not all have the same prognosis.[Resumen]
Introducción y objetivos.
Según las guías de muerte súbita, se debe considerar un desfibrilador automático implantable (DAI) para los pacientes con miocardiopatía dilatada debida a variantes en el gen de la lamina (LMNA) con al menos 2 factores: varones, fracción de eyección del ventrículo izquierdo (FEVI) < 45%, taquicardia ventricular no sostenida (TVNS) y variantes no missense. Nuestro objetivo es describir las características clínicas de una cohorte española de pacientes con cardiolaminopatías (registro REDLAMINA) y evaluar los criterios de riesgo vigentes.
Métodos.
Se evaluó la relación entre factores de riesgo y eventos cardiovasculares en una cohorte de 140 portadores de variantes en LMNA (54 probandos, 86 familiares, edad ≥ 16 años). Se consideró: a) evento arrítmico mayor (EAM) si hubo descarga apropiada del DAI o muerte súbita, y b) muerte por insuficiencia cardiaca, incluidos los trasplantes.
Resultados.
Se identificaron 11 variantes nuevas y 21 previamente publicadas. La FEVI < 45% (p = 0,001) y la TVNS (p < 0,001) se relacionaron con los EAM, pero no el sexo o el tipo de variante (missense frente a no missense). La FEVI < 45% (p < 0,001) fue el único factor relacionado con la muerte por insuficiencia cardiaca.
Conclusiones.
En el registro REDLAMINA, los únicos 2 predictores asociados con EAM fueron la TVNS y la FEVI < 45%. No se debería considerar grupo de bajo riesgo a las portadoras de variantes missense con TVNS o FEVI < 45%. Es importante individualizar la estratificación del riesgo de los portadores de variantes missense en LMNA, porque no todas tienen el mismo pronóstico.This study received a grant from the Proyecto de investigación de la Sección de Insuficiencia Cardiaca 2017 from the Spanish Society of Cardiology and grants from the Instituto de Salud Carlos III (ISCIII) [PI14/0967, PI15/01551, AC16/0014] and ERA-CVD Joint Transnational Call 2016 (Genprovic). Grants from the ISCIII and the Ministerio de Economía y Competitividad de España (Spanish Department of Economy and Competitiveness) are supported by the Plan Estatal de I+D+i 2013-2016: Fondo Europeo de Desarrollo Regional (FEDER) “Una forma de hacer Europa”
- …